REGULATED PRESS RELEASE published on 03/27/2024 at 21:19, 7 months 24 days ago Covivio - Conditions of availability of preparatory documents to the Combined Ordinary and Extraordinary General Meeting of 17 April 2024 Covivio announces availability of preparatory documents for the Combined Ordinary and Extraordinary General Meeting on 17 April 2024. Shareholders can access documents at the company's office or website Shareholders Covivio General Meeting Preparatory Documents Availability
BRIEF published on 03/19/2024 at 19:40, 8 months 1 day ago Covivio Announces Availability of 2023 Universal Registration Document AMF Covivio Corporate Governance Universal Registration Document 2023 Financial Report
REGULATED PRESS RELEASE published on 03/19/2024 at 19:35, 8 months 1 day ago Covivio - Conditions of availability of the 2023 Universal Registration Document Covivio announces availability of its 2023 Universal Registration Document in ESEF format for public access, including financial reports and governance details Governance Covivio Financial Reports Universal Registration Document ESEF Format
REGULATED PRESS RELEASE published on 02/22/2024 at 07:45, 8 months 28 days ago Covivio - Major reinforcement in hotels Covivio reinforces its position in the hotel sector by acquiring Generali's stake in Covivio Hotels, signaling growth in the European hotel market Acquisition Covivio Hotels Growth Prospects European Hotel Market
BRIEF published on 02/22/2024 at 07:45, 8 months 28 days ago Strategic Strengthening of Covivio in the Hotel Sector Acquisition Covivio Hotel Real Estate Hotel Market Tourism Growth
REGULATED PRESS RELEASE published on 02/15/2024 at 19:15, 9 months 5 days ago Covivio - 2023 annual results: Ahead of targets and continued growth in recurring earnings
REGULATED PRESS RELEASE published on 01/18/2024 at 18:46, 10 months 2 days ago Covivio: half-year liquidity contract reporting at 31 December 2023 The half-yearly report on the COVIVIO liquidity contract reveals the allocation of resources to the liquidity account, the negotiations during the second semester 2023, and the daily report for the period from 01/07/2023 to 31/12/2023. COVIVIO, a leading real estate player at the European level, emphasizes sustainable relationships, well-being, and responsible performance as part of its Purpose. Its shares listed in the Euronext Paris A compartment are included in various indices and hold multiple awards and ratings. COVIVIO Liquidity Contract Real Estate Expertise European Culture Sustainable Relationships Responsible Performance
REGULATED PRESS RELEASE published on 11/07/2023 at 19:05, 1 year ago Covivio and AccorInvest enter into exclusive negotiations with a view to consolidating their hotel properties and business assets
REGULATED PRESS RELEASE published on 10/20/2023 at 18:00, 1 year 1 month ago Transfer of Covivio's liquidity contract by EXANE to BNP PARIBAS ARBITRAGE
REGULATED PRESS RELEASE published on 10/19/2023 at 18:00, 1 year 1 month ago Covivio - Activity at end-September 2023: Stronger balance sheet and revenues up +7% like-for-like
Published on 11/21/2024 at 13:00, 40 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 40 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 40 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 13:00, 40 minutes ago Nextech3D.ai Spin-Out Rebrands as FOTOgpt.ai to Usher in a New Era of AI-Powered Photography
Published on 11/21/2024 at 13:00, 40 minutes ago Clean Air Metals Announces Positive Results from Innovative Seismic Survey at the Escape Deposit Down-Plunge Extension
Published on 11/21/2024 at 12:35, 1 hour 4 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 25 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 6 hours 42 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 20 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 19 hours 55 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 19 hours 55 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 5 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo